Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulio Casi

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Molecular Cancer Therapeutics|August 22, 2015
Antibody Format and Drug Release Rate Determine the Therapeutic Activity of Noninternalizing Antibody-Drug ConjugatesRémy Gébleux, Sarah Wulhfard, Giulio Casi, et al.
Chemical Communications (Cambridge, England)|July 6, 2005
Intramolecular addition of cysteine thiyl radicals to phenylalanine in peptides: formation of cyclohexadienyl type radicalsThomas Nauser, Giulio Casi, Willem H Koppenol, et al.
The Journal of Physical Chemistry. B|November 1, 2008
Reversible intramolecular hydrogen transfer between cysteine thiyl radicals and glycine and alanine in model peptides: absolute rate constants derived from pulse radiolysis and laser flash photolysisThomas Nauser, Giulio Casi, Willem H Koppenol, et al.
Chemical Communications (Cambridge, England)|June 12, 2012
Fucose-specific conjugation of hydrazide derivatives to a vascular-targeting monoclonal antibody in IgG formatKathrin Zuberbühler, Giulio Casi, Gonçalo J L Bernardes, et al.
Journal of the American Chemical Society|March 8, 2012
Site-specific traceless coupling of potent cytotoxic drugs to recombinant antibodies for pharmacodeliveryGiulio Casi, Nicolas Huguenin-Dezot, Kathrin Zuberbühler, et al.
Journal of Medicinal Chemistry|October 3, 2003
3,6-dibromocarbazole piperazine derivatives of 2-propanol as first inhibitors of cytochrome c release via Bax channel modulationAgnes Bombrun, Patrick Gerber, Giulio Casi, et al.
Nature Protocols|October 5, 2013
Site-specific chemical modification of antibody fragments using traceless cleavable linkersGonçalo J L Bernardes, Martina Steiner, Isabelle Hartmann, et al.
Angewandte Chemie (International Ed. in English)|December 17, 2011
A traceless vascular-targeting antibody-drug conjugate for cancer therapyGonçalo J L Bernardes, Giulio Casi, Sabrina Trüssel, et al.
Cancer Research|February 13, 2014
Curative properties of noninternalizing antibody-drug conjugates based on maytansinoidsElena Perrino, Martina Steiner, Nikolaus Krall, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Molecular Cancer Therapeutics|August 22, 2015
Antibody Format and Drug Release Rate Determine the Therapeutic Activity of Noninternalizing Antibody-Drug ConjugatesRémy Gébleux, Sarah Wulhfard, Giulio Casi, et al.
Chemical Communications (Cambridge, England)|July 6, 2005
Intramolecular addition of cysteine thiyl radicals to phenylalanine in peptides: formation of cyclohexadienyl type radicalsThomas Nauser, Giulio Casi, Willem H Koppenol, et al.
The Journal of Physical Chemistry. B|November 1, 2008
Reversible intramolecular hydrogen transfer between cysteine thiyl radicals and glycine and alanine in model peptides: absolute rate constants derived from pulse radiolysis and laser flash photolysisThomas Nauser, Giulio Casi, Willem H Koppenol, et al.
Chemical Communications (Cambridge, England)|June 12, 2012
Fucose-specific conjugation of hydrazide derivatives to a vascular-targeting monoclonal antibody in IgG formatKathrin Zuberbühler, Giulio Casi, Gonçalo J L Bernardes, et al.
Journal of the American Chemical Society|March 8, 2012
Site-specific traceless coupling of potent cytotoxic drugs to recombinant antibodies for pharmacodeliveryGiulio Casi, Nicolas Huguenin-Dezot, Kathrin Zuberbühler, et al.
Journal of Medicinal Chemistry|October 3, 2003
3,6-dibromocarbazole piperazine derivatives of 2-propanol as first inhibitors of cytochrome c release via Bax channel modulationAgnes Bombrun, Patrick Gerber, Giulio Casi, et al.
Nature Protocols|October 5, 2013
Site-specific chemical modification of antibody fragments using traceless cleavable linkersGonçalo J L Bernardes, Martina Steiner, Isabelle Hartmann, et al.
Angewandte Chemie (International Ed. in English)|December 17, 2011
A traceless vascular-targeting antibody-drug conjugate for cancer therapyGonçalo J L Bernardes, Giulio Casi, Sabrina Trüssel, et al.
Cancer Research|February 13, 2014
Curative properties of noninternalizing antibody-drug conjugates based on maytansinoidsElena Perrino, Martina Steiner, Nikolaus Krall, et al.
Pageof 2